1.
Report Overview
1.1.
Report Description
1.2.
Research Methods
1.3.
Research Approaches
2.
Executive Summary
3.
Market Overview
3.1.
Introduction
3.2.
Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
3.3.
PEST-Analysis
3.4.
Porter's Diamond Model for France
Immuno Oncology Assays Market
3.5.
IGR-Growth Matrix Analysis
3.6.
Competitive Landscape in France
Immuno Oncology Assays Market
4.
France Immuno Oncology Assays Market by
Product
4.1.
Consumables
4.2.
Software
5.
France Immuno Oncology Assays Market by
Technology
5.1.
PCR
5.2.
Immunoassay
5.3.
NGS
5.4.
Flow Cytometry
5.5.
Other Technology
6.
France Immuno Oncology Assays Market by
Indication
6.1.
Lung Cancer
6.2.
Colorectal Cancer
6.3.
Melanoma
6.4.
Bladder Cancer
6.5.
Other Indication
7.
France Immuno Oncology Assays Market by
Application
7.1.
Research Applications
7.2.
Clinical Diagnostics
8.
Company Profiles
8.1.
Manufacturer's & Suppliers
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.1.4. Company 4
8.1.5. Company 5
1.
Report Overview
1.1.
Report Description
1.2.
Research Methods
1.3.
Research Approaches
2.
Executive Summary
3.
Market Overview
3.1.
Introduction
3.2.
Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
3.3.
PEST-Analysis
3.4.
Porter's Diamond Model for France
Immuno Oncology Assays Market
3.5.
IGR-Growth Matrix Analysis
3.6.
Competitive Landscape in France
Immuno Oncology Assays Market
4.
France Immuno Oncology Assays Market by
Product
4.1.
Consumables
4.2.
Software
5.
France Immuno Oncology Assays Market by
Technology
5.1.
PCR
5.2.
Immunoassay
5.3.
NGS
5.4.
Flow Cytometry
5.5.
Other Technology
6.
France Immuno Oncology Assays Market by
Indication
6.1.
Lung Cancer
6.2.
Colorectal Cancer
6.3.
Melanoma
6.4.
Bladder Cancer
6.5.
Other Indication
7.
France Immuno Oncology Assays Market by
Application
7.1.
Research Applications
7.2.
Clinical Diagnostics
8.
Company Profiles
8.1.
Manufacturer's & Suppliers
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.1.4. Company 4
8.1.5. Company 5